Trial Outcomes & Findings for Post-Approval Clinical Trial Comparing the Long Term Safety and Effectiveness Coflex vs. Fusion to Treat Lumbar Spinal Stenosis (NCT NCT00534235)
NCT ID: NCT00534235
Last Updated: 2020-02-06
Results Overview
The primary variable of performance is the assessment of Oswestry Low Back Pain Disability Index (ODI) in both treatment groups at 5 years. It will be assessed if the improvement in ODI since the pre surgery status in the coflex™ group is better than the improvement in the control group (scale 0-100 with a higher score representing increased disability).
COMPLETED
NA
322 participants
5 years
2020-02-06
Participant Flow
Participant milestones
| Measure |
Posterolateral Fusion w/Pedicle Screws
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Overall Study
STARTED
|
107
|
215
|
|
Overall Study
COMPLETED
|
91
|
192
|
|
Overall Study
NOT COMPLETED
|
16
|
23
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Post-Approval Clinical Trial Comparing the Long Term Safety and Effectiveness Coflex vs. Fusion to Treat Lumbar Spinal Stenosis
Baseline characteristics by cohort
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=107 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=215 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
Total
n=322 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
64.1 years
STANDARD_DEVIATION 9.0 • n=5 Participants
|
62.1 years
STANDARD_DEVIATION 9.2 • n=7 Participants
|
62.8 years
STANDARD_DEVIATION 9.2 • n=5 Participants
|
|
Sex: Female, Male
Female
|
58 Participants
n=5 Participants
|
106 Participants
n=7 Participants
|
164 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
49 Participants
n=5 Participants
|
109 Participants
n=7 Participants
|
158 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
American Indian / Alaskan Native
|
3 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
4 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Asian
|
3 Participants
n=5 Participants
|
4 Participants
n=7 Participants
|
7 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Black or African American
|
6 Participants
n=5 Participants
|
11 Participants
n=7 Participants
|
17 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
White
|
93 Participants
n=5 Participants
|
191 Participants
n=7 Participants
|
284 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Other
|
2 Participants
n=5 Participants
|
8 Participants
n=7 Participants
|
10 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
107 participants
n=5 Participants
|
215 participants
n=7 Participants
|
322 participants
n=5 Participants
|
|
Weight
|
187.7 pounds
STANDARD_DEVIATION 38.1 • n=5 Participants
|
190.3 pounds
STANDARD_DEVIATION 35.4 • n=7 Participants
|
189.5 pounds
STANDARD_DEVIATION 36.3 • n=5 Participants
|
|
Height
|
66.6 inches
STANDARD_DEVIATION 4.1 • n=5 Participants
|
67.0 inches
STANDARD_DEVIATION 4.1 • n=7 Participants
|
66.9 inches
STANDARD_DEVIATION 4.1 • n=5 Participants
|
|
Current Smoker
Yes
|
15 Participants
n=5 Participants
|
22 Participants
n=7 Participants
|
37 Participants
n=5 Participants
|
|
Current Smoker
No
|
92 Participants
n=5 Participants
|
193 Participants
n=7 Participants
|
285 Participants
n=5 Participants
|
|
Comorbidities
Cardiovascular
|
74 Participants
n=5 Participants
|
137 Participants
n=7 Participants
|
211 Participants
n=5 Participants
|
|
Comorbidities
Musculoskeletal
|
61 Participants
n=5 Participants
|
112 Participants
n=7 Participants
|
173 Participants
n=5 Participants
|
|
Comorbidities
Endocrine
|
35 Participants
n=5 Participants
|
55 Participants
n=7 Participants
|
90 Participants
n=5 Participants
|
|
Duration of Back Pain
None
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Duration of Back Pain
Fewer than 6 months
|
1 Participants
n=5 Participants
|
3 Participants
n=7 Participants
|
4 Participants
n=5 Participants
|
|
Duration of Back Pain
6 months to a year
|
14 Participants
n=5 Participants
|
24 Participants
n=7 Participants
|
38 Participants
n=5 Participants
|
|
Duration of Back Pain
More than one year
|
92 Participants
n=5 Participants
|
188 Participants
n=7 Participants
|
280 Participants
n=5 Participants
|
|
Duration of Leg Pain (maximum)
None
|
1 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
2 Participants
n=5 Participants
|
|
Duration of Leg Pain (maximum)
Fewer than 6 months
|
8 Participants
n=5 Participants
|
6 Participants
n=7 Participants
|
14 Participants
n=5 Participants
|
|
Duration of Leg Pain (maximum)
6 months to a year
|
22 Participants
n=5 Participants
|
38 Participants
n=7 Participants
|
60 Participants
n=5 Participants
|
|
Duration of Leg Pain (maximum)
More than one year
|
76 Participants
n=5 Participants
|
170 Participants
n=7 Participants
|
246 Participants
n=5 Participants
|
|
Duration of Buttock Pain
None
|
21 Participants
n=5 Participants
|
32 Participants
n=7 Participants
|
53 Participants
n=5 Participants
|
|
Duration of Buttock Pain
Fewer than 6 months
|
7 Participants
n=5 Participants
|
11 Participants
n=7 Participants
|
18 Participants
n=5 Participants
|
|
Duration of Buttock Pain
6 months to a year
|
22 Participants
n=5 Participants
|
41 Participants
n=7 Participants
|
63 Participants
n=5 Participants
|
|
Duration of Buttock Pain
More than one year
|
57 Participants
n=5 Participants
|
131 Participants
n=7 Participants
|
188 Participants
n=5 Participants
|
|
Duration of Groin Pain
None
|
74 Participants
n=5 Participants
|
157 Participants
n=7 Participants
|
231 Participants
n=5 Participants
|
|
Duration of Groin Pain
Fewer than 6 months
|
5 Participants
n=5 Participants
|
6 Participants
n=7 Participants
|
11 Participants
n=5 Participants
|
|
Duration of Groin Pain
6 months to a year
|
12 Participants
n=5 Participants
|
13 Participants
n=7 Participants
|
25 Participants
n=5 Participants
|
|
Duration of Groin Pain
More than one year
|
16 Participants
n=5 Participants
|
39 Participants
n=7 Participants
|
55 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 5 yearsPopulation: The accounting #s in the Patient Flow include all subjects available for CCS evaluation; therefore, the overall # of participants analyzed for each Outcome Measure will differ from the number provided in the Participant Flow as the number provided for each Outcome Measure is the number of patients who completed or were assessed for that measure.
The primary variable of performance is the assessment of Oswestry Low Back Pain Disability Index (ODI) in both treatment groups at 5 years. It will be assessed if the improvement in ODI since the pre surgery status in the coflex™ group is better than the improvement in the control group (scale 0-100 with a higher score representing increased disability).
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=54 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=126 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Number of Subjects With Improvement of at Least 15 Points in ODI
|
41 Participants
|
101 Participants
|
PRIMARY outcome
Timeframe: 5 yearsAssessment of secondary surgical interventions, i.e., reoperations, revisions, removals, or supplemental fixation associated with either coflex or control group. Refer to FDA guidance for complete definitions (https://www.fda.gov/RegulatoryInformation/Guidances/ucm072263.htm).
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=107 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=215 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Number of Subjects With no Reoperations, Revisions, Removals, or Supplemental Fixation
|
87 Participants
|
179 Participants
|
PRIMARY outcome
Timeframe: 5 yearsAssessment of major device-related complications at 5 years
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=107 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=215 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Number of Subjects With no Major Device Related Complications
|
100 Participants
|
212 Participants
|
PRIMARY outcome
Timeframe: 5 yearsAssessment of lumbar epidural injections
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=107 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=215 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Number of Subjects With no Epidural Injection(s)
|
84 Participants
|
177 Participants
|
PRIMARY outcome
Timeframe: 5 yearsNo persistent new or increasing sensory or motor deficit
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=74 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=145 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Number of Subjects With no Persistent New or Increasing Sensory or Motor Deficit
|
70 Participants
|
135 Participants
|
PRIMARY outcome
Timeframe: 5 yearsNo persistent new or increasing sensory deficit
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=75 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=146 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Number of Subjects With no Persistent New or Increasing Sensory Deficit
|
72 Participants
|
137 Participants
|
PRIMARY outcome
Timeframe: 5 yearsNo persistent new or increasing motor deficit
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=74 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=146 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Number of Subjects With no Persistent New or Increasing Motor Deficit
|
72 Participants
|
144 Participants
|
PRIMARY outcome
Timeframe: 5 yearsNo reoperations, revisions, removals or supplemental fixation and no epidural injection at any lumbar level up to and including the Month 60 visit.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=107 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=215 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Number of Subjects With no Reoperations or Epidural (Up to Day 1825)
|
71 Participants
|
149 Participants
|
SECONDARY outcome
Timeframe: 5 yearsZCQ is a scale that measures physical function, symptom severity, and patient satisfaction for patients with spinal stenosis. Scores range from 1-5 with a higher score indicating worsening disability.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=54 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=126 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Number of Subjects With a Decrease in Zurich Claudication Questionnaire (ZCQ) Symptom Severity of at Least 0.5 Points
|
40 Participants
|
100 Participants
|
SECONDARY outcome
Timeframe: 5 yearsZCQ is a scale that measures physical function, symptom severity, and patient satisfaction for patients with spinal stenosis.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=54 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=126 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Number of Subjects With Decrease in Zurich Claudication Questionnaire (ZCQ) Physical Function of at Least 0.5 Points
|
38 Participants
|
98 Participants
|
SECONDARY outcome
Timeframe: 5 yearsAssessment of the patient's Quality of Life as measured by SF-12. Scores range from 0 to 100, where a zero score indicates the lowest level of health. Success was defined as subjects who maintained or improved from their SF-12 score at baseline.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=44 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=106 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Number of Subjects With Maintenance or Improvement in SF-12 Physical Function Component
|
34 Participants
|
93 Participants
|
SECONDARY outcome
Timeframe: 5 yearsAssessment of the patient's Quality of Life as measured by SF-12. Scores range from 0 to 100, where a zero score indicates the lowest level of health. Success was defined as subjects who maintained or improved from their SF-12 score at baseline.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=44 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=106 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Number of Subjects With Maintenance or Improvement in SF-12 Mental Health Component
|
31 Participants
|
72 Participants
|
SECONDARY outcome
Timeframe: 5 yearsImprovement of the Visual Analog Scale (VAS) for low back pain (on the 100 mm scale) compared to control group. On a scale of 0 to 100, 0 indicates no pain and 100 indicates worst pain imaginable.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=53 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=124 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Number of Subjects With a Decrease in VAS Back Pain of at Least 20mm
|
40 Participants
|
104 Participants
|
SECONDARY outcome
Timeframe: 5 yearsImprovement of the Visual Analog Scale (VAS) for leg pain (on the 100 mm scale) compared to control group. On a scale of 0 to 100, 0 indicates no pain and 100 indicates worst pain imaginable.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=53 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=124 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Number of Subjects With Decrease VAS Worse Leg Pain of at Least 20mm
|
41 Participants
|
99 Participants
|
SECONDARY outcome
Timeframe: 5 yearsAssessment of disability from low back pain as measured by ODI (Oswestry Disability Index) mean score in each treatment group at 5 years. On a scale of 0-100, a higher score represents increased disability.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=54 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=126 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Mean Oswestry Disability Index (ODI) Score
|
26.1 units on a scale
Standard Deviation 22.2
|
24.5 units on a scale
Standard Deviation 20.5
|
SECONDARY outcome
Timeframe: 5 yearsAssessment of Back Pain as measured by VAS mean score in each treatment group at 5 years. On a scale of 0-100mm, a higher score represents worse pain.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=54 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=124 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Mean Visual Analog Scale Back Pain Score
|
29.0 mm
Standard Deviation 31.0
|
25.4 mm
Standard Deviation 27.6
|
SECONDARY outcome
Timeframe: 5 yearsAssessment of Worse Leg Pain by VAS mean score in each treatment group at 5 years. On a scale of 0-100mm, a higher score represents worse pain.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=54 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=124 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Mean Visual Analog Scale Leg (Worse) Pain Score
|
25.2 mm
Standard Deviation 31.2
|
22.8 mm
Standard Deviation 28.1
|
SECONDARY outcome
Timeframe: 5 yearsAssessment of Right Leg Pain by VAS mean score in each treatment group at 5 years. On a scale of 0-100mm, a higher score represents worse pain.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=54 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=124 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Mean Visual Analog Scale (VAS) Leg (Right) Pain Score
|
16.0 mm
Standard Deviation 24.5
|
14.9 mm
Standard Deviation 21.6
|
SECONDARY outcome
Timeframe: 5 yearsAssessment of Left Leg Pain by VAS mean score in both treatment groups at 5 years. On a scale of 0-100mm, a higher score represents worse pain.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=54 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=124 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Mean Visual Analog Scale (VAS) Leg (Left) Pain Score
|
17.0 mm
Standard Deviation 26.8
|
18.4 mm
Standard Deviation 27.0
|
SECONDARY outcome
Timeframe: 5 yearsImprovement of the Visual Analog Scale (VAS) for low back pain (on the 100 mm scale) compared to control group. On a scale of 0 to 100, 0 indicates no pain and 100 indicates worst pain imaginable.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=53 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=124 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Number of Subjects With a Decrease in VAS Right Leg Pain of at Least 20mm
|
36 Participants
|
90 Participants
|
SECONDARY outcome
Timeframe: 5 yearsImprovement of the Visual Analog Scale (VAS) for low back pain (on the 100 mm scale) compared to control group. On a scale of 0 to 100, 0 indicates no pain and 100 indicates worst pain imaginable.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=53 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=122 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Number of Subjects With a Decrease in VAS Left Leg Pain of at Least 20mm
|
37 Participants
|
78 Participants
|
SECONDARY outcome
Timeframe: 5 yearsAssessment of symptom severity by ZCQ mean score in both treatment groups at 5 years. ZCQ is a scale that measures physical function, symptom severity, and patient satisfaction for patients with spinal stenosis. Scores range from 1-5 with a higher score indicating worsening disability.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=54 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=126 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Mean Zurich Claudication Questionnaire (ZCQ) Symptom Severity Score
|
2.17 units on a scale
Standard Deviation 0.85
|
2.08 units on a scale
Standard Deviation 0.84
|
SECONDARY outcome
Timeframe: 5 yearsAssessment of physical function by ZCQ mean score in both groups at 5 years. ZCQ is a scale that measures physical function, symptom severity, and patient satisfaction for patients with spinal stenosis. Scores range from 1-5 with a higher score indicating worsening disability.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=54 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=126 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Mean Zurich Claudication Questionnaire (ZCQ) Physical Function Score
|
1.81 units on a scale
Standard Deviation 0.79
|
1.67 units on a scale
Standard Deviation 0.68
|
SECONDARY outcome
Timeframe: 5 yearsAssessment of the patient's Quality of Life as measured by SF-12 mean score in both treatment groups at 5 years. Scores range from 0 to 100, where a zero score indicates the lowest level of health.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=47 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=118 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Mean Short Form-12 Physical Component Score
|
42.1 units on a scale
Standard Deviation 12.6
|
42.1 units on a scale
Standard Deviation 11.2
|
SECONDARY outcome
Timeframe: 5 yearsAssessment of the patient's Quality of Life as measured by SF-12 mean score in both treatment groups at 5 years. Scores range from 0 to 100, where a zero score indicates the lowest level of health.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=47 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=118 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Mean Short Form-12 Mental Component Score
|
54.8 units on a scale
Standard Deviation 8.4
|
54.1 units on a scale
Standard Deviation 9.7
|
SECONDARY outcome
Timeframe: 5 yearsSubjects who responded "Very Satisfied" or "Somewhat Satisfied".
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=87 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=160 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Patient Survey: Satisfaction
|
72 Participants
|
151 Participants
|
SECONDARY outcome
Timeframe: 5 yearsSubjects who responded "Definitely Yes" or "Probably Yes"
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=87 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=160 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Patient Survey: Recommendation of Treatment
|
70 Participants
|
145 Participants
|
SECONDARY outcome
Timeframe: 5 yearsNumber of subjects using Class II narcotics
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=81 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=156 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Pain Management: Class II Narcotics Usage by Device Group
|
17 Participants
|
32 Participants
|
SECONDARY outcome
Timeframe: 5 yearsNumber of subjects using NSAIDs/ASA/Acetaminophen
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=81 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=156 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Pain Management: NSAIDs/ASA/Acetaminophen Usage by Device Group
|
24 Participants
|
55 Participants
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 5 yearsPopulation: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.
As determined by independent radiographic lab, this is the average measure of rotation (flexion to extension) at the index level(s) in both treatment groups at 5 years.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=105 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=205 Levels
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Mean Rotation (F to E) in Degrees - At Level(s) of Implant
|
0.98 degrees
Standard Deviation 1.17
|
3.13 degrees
Standard Deviation 3.43
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 5 yearsPopulation: This analysis was performed at the level below the 1- or 2-level device construct in both groups.
As determined by independent radiographic lab, this is the average measure of rotation (flexion to extension) at the level below the implant in both treatment groups at 5 years.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=74 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=140 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Rotation (F to E) in Degrees - Below Level of Implant
|
5.62 degrees
Standard Deviation 3.69
|
5.83 degrees
Standard Deviation 4.17
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 5 yearsPopulation: This analysis was performed at the level above the 1- or 2-level device construct in both groups.
As determined by independent radiographic lab, this is the average measure of rotation (flexion to extension) at the level above the implant in both treatment groups at 5 years.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=76 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=146 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Rotation (F to E) in Degrees - Above Level of Implant
|
3.59 degrees
Standard Deviation 2.89
|
3.52 degrees
Standard Deviation 3.16
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 5 yearsPopulation: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.
As determined by independent radiographic lab, this is the average measure of translation at the index level(s) in both treatment groups at 5 years.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=103 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=204 Levels
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Translation (mm) - At Level(s) of Implant
|
0.23 mm
Standard Deviation 0.32
|
0.82 mm
Standard Deviation 0.84
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 5 yearsPopulation: This analysis was performed at the level below the 1- or 2-level device construct in both groups.
As determined by independent radiographic lab, this is the average measure of translation at the level below the implant in both treatment groups at 5 years.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=72 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=139 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Translation (mm) - Below Level of Implant
|
0.63 mm
Standard Deviation 0.57
|
0.64 mm
Standard Deviation 0.61
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 5 yearsPopulation: This analysis was performed at the level above the 1- or 2-level device construct in both groups.
As determined by independent radiographic lab, this is the average measure of translation at the level above the implant in both treatment groups at 5 years.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=74 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=145 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Translation (mm) - Above Level of Implant
|
0.69 mm
Standard Deviation 0.57
|
0.83 mm
Standard Deviation 0.80
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 5 yearsPopulation: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.
As determined by independent radiographic lab, this is the average measure of anterior disc height at the index level(s) in both treatment groups at 5 years.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=108 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=205 Levels
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Anterior Disc Height (mm) - At Level(s) of Implant
|
8.13 mm
Standard Deviation 3.19
|
8.89 mm
Standard Deviation 3.68
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 5 yearsPopulation: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.
As determined by independent radiographic lab, this is the average measure of posterior disc height at the index level(s) in both treatment groups at 5 years.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=108 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=205 Levels
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Posterior Disc Height (mm) - At Level(s) of Implant
|
4.56 mm
Standard Deviation 1.65
|
4.46 mm
Standard Deviation 1.89
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 5 yearsPopulation: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.
As determined by independent radiographic lab, this is the percentage of translation at the index level(s) in both treatment groups at 5 years.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=105 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=205 Levels
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Translation (F to E) in Percent (%) - At Level(s) of Implant
|
0.69 percent
Standard Deviation 0.89
|
2.38 percent
Standard Deviation 2.43
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 5 yearsPopulation: This analysis was performed at the level below the 1- or 2-level device construct in both groups.
As determined by independent radiographic lab, this is the percentage of translation at the level below the implant in both treatment groups at 5 years.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=74 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=140 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Translation (F to E) in Percent (%) - Below Level of Implant
|
1.95 percent
Standard Deviation 1.95
|
1.97 percent
Standard Deviation 1.88
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 5 yearsPopulation: This analysis was performed at the level above the 1- or 2-level device construct in both groups.
As determined by independent radiographic lab, this is the percentage of translation at the level above the implant in both treatment groups at 5 years.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=76 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=146 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Translation (F to E) in Percent (%) - Above Level of Implant
|
2.07 percent
Standard Deviation 1.68
|
2.40 percent
Standard Deviation 2.31
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 5 yearsPopulation: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.
As determined by independent radiographic lab, this is the average measure of disc height at the index level(s) in both treatment groups at 5 years.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=108 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=205 Levels
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Average Disc Height (mm) - At Level(s) of Implant
|
6.34 mm
Standard Deviation 2.09
|
6.67 mm
Standard Deviation 2.45
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 5 yearsPopulation: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.
As determined by independent radiographic lab, this is the average change from baseline for anterior disc height at the index level(s) in both treatment groups at 5 years.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=106 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=200 Levels
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Change From Pre-Op Anterior Disc Height (mm) - At Level(s) of Implant
|
-1.38 mm
Standard Deviation 1.58
|
-1.32 mm
Standard Deviation 1.75
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 5 yearsPopulation: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.
As determined by independent radiographic lab, this is the average change from baseline for posterior disc height at the index level(s) in both treatment groups at 5 years.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=106 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=149 Participants
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Change From Pre-Op Posterior Disc Height (mm) - At Level(s) of Implant
|
-0.49 mm
Standard Deviation 1.19
|
-0.72 mm
Standard Deviation 1.26
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 5 yearsPopulation: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.
As determined by independent radiographic lab, this is the average change from baseline for disc height at the index level(s) in both treatment groups at 5 years.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=106 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=200 Levels
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Change From Pre-Op Average Disc Height (mm) - At Level(s) of Implant
|
-0.93 mm
Standard Deviation 1.02
|
-1.02 mm
Standard Deviation 1.24
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 5 yearsPopulation: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.
As determined by independent radiographic lab, this is the average change from immediate post-op for anterior disc height at the index level(s) in both treatment groups at 5 years.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=108 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=205 Levels
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Change From Post-Op Anterior Disc Height (mm) - At Level(s) of Implant
|
-1.82 mm
Standard Deviation 1.39
|
-0.98 mm
Standard Deviation 2.06
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 5 yearsPopulation: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.
As determined by independent radiographic lab, this is the average change from immediate post-op for posterior disc height at the index level(s) in both treatment groups at 5 years.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=108 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=205 Levels
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Change From Post-Op Posterior Disc Height (mm) - At Level(s) of Implant
|
-0.85 mm
Standard Deviation 1.00
|
-1.90 mm
Standard Deviation 1.65
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 5 yearsPopulation: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.
As determined by independent radiographic lab, this is the average change from immediate post-op for disc height at the index level(s) in both treatment groups at 5 years.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=108 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=205 Levels
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Change From Post-Op Average Disc Height (mm) - At Level(s) of Implant
|
-1.33 mm
Standard Deviation 0.97
|
-1.44 mm
Standard Deviation 1.47
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 5 yearsPopulation: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.
As determined by independent radiographic lab, this is the mean disc angle at the index level(s) in both treatment groups at 5 years.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=111 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=205 Levels
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Disc Angle in Degrees - At Level(s) of Implant
|
6.02 degrees
Standard Deviation 4.64
|
7.28 degrees
Standard Deviation 5.19
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 5 yearsPopulation: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.
As determined by independent radiographic lab, this is the mean change in disc angle from baseline at the index level(s) in both treatment groups at 5 years.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=109 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=200 Levels
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Change From Pre-Op Disc Angle in Degrees - At Level(s) of Implant
|
-1.41 degrees
Standard Deviation 3.10
|
-1.00 degrees
Standard Deviation 2.91
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 5 yearsPopulation: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.
As determined by independent radiographic lab, this is the mean change in disc angle from immediate post-op at the index level(s) in both treatment groups at 5 years.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=111 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=205 Levels
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Change From Post-Op Disc Angle in Degrees - At Level(s) of Implant
|
-1.57 degrees
Standard Deviation 2.25
|
1.56 degrees
Standard Deviation 3.82
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 5 yearsPopulation: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.
As determined by independent radiographic lab, this is the measure of spondylolisthesis at the index level(s) in both treatment groups at 5 years.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=108 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=205 Levels
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Change From Post-Op Spondylolisthesis (mm) - At Level(s) of Implant
|
-1.08 mm
Standard Deviation 3.37
|
-1.01 mm
Standard Deviation 3.78
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 5 yearsPopulation: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.
As determined by independent radiographic lab, this is the measure of the percentage of spondylolisthesis at the index level(s) in both treatment groups at 5 years.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=108 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=205 Levels
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Change From Post-Op Spondylolisthesis (%) - At Level(s) of Implant
|
-3.4 percent
Standard Deviation 9.9
|
-3.2 percent
Standard Deviation 11.2
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 5 yearsPopulation: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.
As determined by independent radiographic lab, this is the mean change in measure of spondylolisthesis at the index level(s) in both treatment groups at 5 years.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=106 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=200 Levels
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Change From Pre-Op Spondylolisthesis (mm) - At Level(s) of Implant
|
-0.12 mm
Standard Deviation 2.28
|
-0.56 mm
Standard Deviation 1.82
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 5 yearsPopulation: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.
As determined by independent radiographic lab, this is the mean change in measure of spondylolisthesis from immediate post-op at the index level(s) in both treatment groups at 5 years.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=108 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=205 Levels
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Change From Post-Op Spondylolisthesis (mm) - At Level(s) of Implant
|
-0.77 mm
Standard Deviation 1.92
|
-0.44 mm
Standard Deviation 1.91
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 5 yearsPopulation: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.
This is the mean foraminal height via x-ray at the index level(s) in both treatment groups at 5 years.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=205 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Foraminal Height (X-ray) (mm) - At Level(s) of Implant
|
17.33 mm
Standard Deviation 2.75
|
—
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 5 yearsPopulation: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.
This is the mean change in foraminal height via x-ray from baseline at the index level(s) in both treatment groups at 5 years.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=200 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Change From Pre-Op Foraminal Height (X-ray) (mm) - At Level(s) of Implant
|
-0.47 mm
Standard Deviation 1.29
|
—
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 5 yearsPopulation: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.
This is the mean change in foraminal height via x-ray from immediate post-op at the index level(s) in both treatment groups at 5 years.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=149 Participants
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Change From Post-Op Foraminal Height (X-ray) (mm) - At Level(s) of Implant
|
-1.81 mm
Standard Deviation 1.74
|
—
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 5 yearsPopulation: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.
Bridging through the posterolateral gutters, between the facet joints, between transverse processes, and/or between facet joint and transverse process will all be considered acceptable forms of bridging bone.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=111 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=209 Levels
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Bony Bridging
NA
|
0 Levels
|
209 Levels
|
|
Bony Bridging
No
|
17 Levels
|
0 Levels
|
|
Bony Bridging
Yes
|
84 Levels
|
0 Levels
|
|
Bony Bridging
Indeterminate
|
10 Levels
|
0 Levels
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 5 yearsPopulation: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.
Assessment applicable to coflex arm only. The assessment applies to bony formations that occur in and around the implant.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=209 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Heterotopic Ossification
NA
|
0 participants
|
—
|
|
Heterotopic Ossification
None
|
91 participants
|
—
|
|
Heterotopic Ossification
Grade I
|
0 participants
|
—
|
|
Heterotopic Ossification
Grade II
|
24 participants
|
—
|
|
Heterotopic Ossification
Grade III
|
73 participants
|
—
|
|
Heterotopic Ossification
Bony Bridging
|
3 participants
|
—
|
|
Heterotopic Ossification
Indeterminate
|
18 participants
|
—
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 5 yearsPopulation: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.
The assessment is an analysis of three component factors: Bridging Bone, Angular Motion and Translational Motion.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=111 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=209 Levels
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Fusion Status
NA
|
0 Levels
|
0 Levels
|
|
Fusion Status
Not fused
|
19 Levels
|
196 Levels
|
|
Fusion Status
Fused
|
78 Levels
|
3 Levels
|
|
Fusion Status
Indeterminate
|
14 Levels
|
10 Levels
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 5 yearsPopulation: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.
Per level; Assessment applicable to coflex arm only. This is an assessment of the bone-implant interface.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=209 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Interface Remodeling - At Level(s) of Implant
NA
|
0 Levels
|
—
|
|
Interface Remodeling - At Level(s) of Implant
None
|
75 Levels
|
—
|
|
Interface Remodeling - At Level(s) of Implant
Mild
|
70 Levels
|
—
|
|
Interface Remodeling - At Level(s) of Implant
Moderate
|
16 Levels
|
—
|
|
Interface Remodeling - At Level(s) of Implant
Severe
|
20 Levels
|
—
|
|
Interface Remodeling - At Level(s) of Implant
Indeterminate
|
28 Levels
|
—
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 5 yearsPopulation: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.
Per level; Assessment only applicable to coflex group. Device Condition in the investigational subjects was graded as: Intact, Deformed, Fractured, Migrated, or Dislodged.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=209 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Device Condition (Coflex Arm)
NA
|
0 Levels
|
—
|
|
Device Condition (Coflex Arm)
Intact
|
184 Levels
|
—
|
|
Device Condition (Coflex Arm)
Deformed
|
0 Levels
|
—
|
|
Device Condition (Coflex Arm)
Fractured
|
3 Levels
|
—
|
|
Device Condition (Coflex Arm)
Migrated
|
11 Levels
|
—
|
|
Device Condition (Coflex Arm)
Dislodged
|
0 Levels
|
—
|
|
Device Condition (Coflex Arm)
Indeterminate
|
11 Levels
|
—
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 5 yearsPopulation: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.
Per level; This assessment is applicable to the fusion arm only. Device Condition in the control subjects will be graded as: Intact, Loose Screws, or Failed Hardware.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=111 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Device Condition (Fusion Control)
NA
|
0 Levels
|
—
|
|
Device Condition (Fusion Control)
Intact
|
90 Levels
|
—
|
|
Device Condition (Fusion Control)
Failed Graft
|
0 Levels
|
—
|
|
Device Condition (Fusion Control)
Loose Screws
|
10 Levels
|
—
|
|
Device Condition (Fusion Control)
Fractured Hardware
|
2 Levels
|
—
|
|
Device Condition (Fusion Control)
Indeterminate
|
9 Levels
|
—
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 5 yearsPopulation: This analysis was performed at each level implanted. Since there were subjects with 2 levels implanted, the number of levels is greater than the number of patients.
Per level; Assessment is applicable to coflex arm only. Device Mobility is an expected occurrence in some subjects and represents the amount of the of lift-off of the implant from the inferior spinous process.
Outcome measures
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=209 Levels
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Device Mobility
< 5 mm
|
181 Levels
|
—
|
|
Device Mobility
>= 5 mm
|
15 Levels
|
—
|
|
Device Mobility
Indeterminate
|
13 Levels
|
—
|
|
Device Mobility
NA
|
0 Levels
|
—
|
Adverse Events
Posterolateral Fusion w/Pedicle Screws
Coflex Interlaminar Technolgy
Serious adverse events
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=107 participants at risk
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=215 participants at risk
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Musculoskeletal and connective tissue disorders
Component Loosening
|
4.7%
5/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
1.4%
3/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
|
Musculoskeletal and connective tissue disorders
Component Breakage
|
0.93%
1/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
0.00%
0/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
|
Musculoskeletal and connective tissue disorders
Tear > 5mm
|
0.93%
1/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
0.00%
0/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
|
Musculoskeletal and connective tissue disorders
Fracture
|
0.93%
1/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
1.9%
4/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
|
Musculoskeletal and connective tissue disorders
Hematoma Requiring Drainage
|
0.93%
1/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
0.00%
0/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
|
Musculoskeletal and connective tissue disorders
Infection (deep)
|
0.00%
0/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
0.93%
2/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
|
Musculoskeletal and connective tissue disorders
Pain; new, increased frequency, or worsening
|
17.8%
19/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
13.5%
29/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
|
Musculoskeletal and connective tissue disorders
Pseudarthrosis
|
1.9%
2/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
0.00%
0/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
|
Musculoskeletal and connective tissue disorders
Wound problems
|
1.9%
2/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
2.8%
6/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
|
Metabolism and nutrition disorders
Other
|
10.3%
11/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
4.7%
10/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Cancer/Neoplasm
|
9.3%
10/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
2.3%
5/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
|
Cardiac disorders
Cardiovascular
|
4.7%
5/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
7.9%
17/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
|
Ear and labyrinth disorders
Eye, Ear, Nose and Throat (EENT)
|
0.93%
1/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
0.47%
1/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
|
Endocrine disorders
Endocrine/Metabolic
|
1.9%
2/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
1.9%
4/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
|
Gastrointestinal disorders
Gastrointestinal
|
5.6%
6/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
4.7%
10/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
|
General disorders
Genitourinary
|
4.7%
5/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
2.3%
5/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
|
Blood and lymphatic system disorders
Hematological
|
0.00%
0/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
0.47%
1/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
|
Musculoskeletal and connective tissue disorders
Musculoskeletal
|
15.0%
16/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
14.9%
32/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
|
Nervous system disorders
Neurological
|
3.7%
4/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
2.3%
5/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
|
Psychiatric disorders
Psychiatric/Substance Abuse
|
2.8%
3/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
0.00%
0/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
|
Respiratory, thoracic and mediastinal disorders
Respiratory
|
0.00%
0/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
2.3%
5/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
|
Skin and subcutaneous tissue disorders
Skin and Subcutaneous
|
0.93%
1/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
0.47%
1/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
Other adverse events
| Measure |
Posterolateral Fusion w/Pedicle Screws
n=107 participants at risk
Control: Posterolateral fusion and implantation of pedicle screws after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Posterolateral Fusion and Implantation of Pedicle Screws
|
Coflex Interlaminar Technolgy
n=215 participants at risk
Investigative: Implantation of coflex Interlaminar Technology after decompression
Decompression: Either microsurgical decompression or laminotomy to remove bone impinging on nerves causes the patient pain
Implantation of coflex Interlaminar Technology
|
|---|---|---|
|
Musculoskeletal and connective tissue disorders
Component Loosening
|
1.9%
2/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
0.47%
1/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
|
Musculoskeletal and connective tissue disorders
Component Migration
|
0.93%
1/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
1.4%
3/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
|
Musculoskeletal and connective tissue disorders
Component Breakage
|
0.93%
1/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
1.4%
3/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
|
Musculoskeletal and connective tissue disorders
Incidental Durotomy (<= 5mm)
|
0.00%
0/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
0.47%
1/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
|
Musculoskeletal and connective tissue disorders
Fracture
|
0.93%
1/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
3.7%
8/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
|
Musculoskeletal and connective tissue disorders
Nerve Injury
|
0.93%
1/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
0.00%
0/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
|
Musculoskeletal and connective tissue disorders
Pain; new, increased frequency, or worsening
|
27.1%
29/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
28.4%
61/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
|
Musculoskeletal and connective tissue disorders
Pseudarthrosis
|
0.93%
1/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
0.00%
0/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
|
Musculoskeletal and connective tissue disorders
Wound problems
|
8.4%
9/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
11.2%
24/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
|
Musculoskeletal and connective tissue disorders
Other
|
18.7%
20/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
21.4%
46/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Cancer/Neoplasm
|
1.9%
2/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
2.8%
6/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
|
Cardiac disorders
Cardiovascular
|
10.3%
11/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
7.0%
15/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
|
Ear and labyrinth disorders
Eye, Ear, Nose, Throat (EENT)
|
3.7%
4/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
3.7%
8/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
|
Endocrine disorders
Endocrine/Metabolic
|
4.7%
5/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
4.7%
10/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
|
Gastrointestinal disorders
Gastrointestinal
|
10.3%
11/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
5.1%
11/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
|
General disorders
Genitourinary
|
7.5%
8/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
5.1%
11/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
|
Blood and lymphatic system disorders
Hematological
|
5.6%
6/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
3.3%
7/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
|
Immune system disorders
Immune
|
0.00%
0/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
0.93%
2/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
|
Musculoskeletal and connective tissue disorders
Musculoskeletal
|
60.7%
65/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
55.3%
119/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
|
Nervous system disorders
Neurological
|
21.5%
23/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
26.0%
56/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
|
Psychiatric disorders
Psychiatric/Substance abuse
|
4.7%
5/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
0.47%
1/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
|
Respiratory, thoracic and mediastinal disorders
Respiratory
|
6.5%
7/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
3.3%
7/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
|
Skin and subcutaneous tissue disorders
Skin and Subcutaneous Tissue
|
8.4%
9/107 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
7.4%
16/215 • 5 years
In place of serious adverse event (SAE), this study used Severe AE (reported in SAE section as device related Severe AE): * is life threatening * results in permanent impairment of a body function or permanent damage to a body structure; or * necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place